Abstract
By functioning as a soluble analogue of the membrane lipid phosphatidylinositol-3,4,5-trisphosphate (here termed PtdInsP3), inositol-1,3,4,5-tetrakisphosphate (here termed InsP4) can control the functions of phosphoinositide 3-kinases (PI3Ks), phosphatase and tensin homologue (PTEN), SH2-domain-containing inositol-5-phosphatase 1 (SHIP1) and SHIP2 — the kinases that produce and the phosphatases that metabolize PtdInsP3 in lymphocytes. InsP4 probably has additional functions that might include those of the many InsP4 derivatives. In the best understood mechanism so far, InsP4 regulates the membrane recruitment of proteins by promoting or inhibiting the interactions of their pleckstrin-homology (PH) domains with PtdInsP3. In mouse thymocytes, positive regulation of inducible T cell kinase (ITK) membrane recruitment by InsP4 establishes a feedback loop of phospholipase Cγ1 activation downstream of the T cell receptor that is essential for the production of sufficient amounts of the second messenger lipid diacylglycerol to trigger positive selection and the generation of a mature T cell repertoire. These findings identified the first physiological function of InsP4 as an essential soluble messenger molecule, two decades after its original discovery. Unexpectedly, defective function of the InsP4-producing kinase ITPKC in humans might result in peripheral T cell hyperactivation and contribute to Kawasaki disease, which is the leading cause of acquired heart disease among children in developed countries. The InsP4-producing kinase ITPKB is required for B cell development and functional competence, as shown by the B cell developmental defects and anergy in Itpkb−/− mice. The mechanisms through which ITPKB controls B cell development are unclear but might include inhibition of store-operated Ca2+ entry (SOCE) by InsP4 through an as yet unknown mechanism. ITPKB limits SOCE and PtdInsP3-mediated membrane recruitment of the PI3K effector kinase AKT in neutrophils. Defects in these processes and in the production of opsonizing IgG by B cells probably underlie a complex phenotype of increased neutrophil chemotaxis and superoxide production, but decreased neutrophil viability and bacterial clearance, in an acute peritonitis model in Itpkb−/− mice. As key regulators of PI3K function with essential roles in the adaptive and innate immune system and unique structural features that facilitate the development of selective inhibitors, the InsP4-producing ITPKs are attractive targets for the development of novel anti-inflammatory therapies, improved vaccination strategies or methods to overcome immunodeficiencies. However, more detailed studies in relevant disease models and with proof-of-concept small molecule inhibitors are required to establish indications, evaluate potential side effects and address toxicity concerns.

This publication has 142 references indexed in Scilit: